ASCAT 2023 | The importance of RBC exchange transfusions for managing fat embolism syndrome in SCD
Perla Eleftheriou, MD, MRCP, FRCPath, University College London Hospitals NHS Foundation Trust, London, UK, speaks on fat embolism syndrome (FES) in sickle cell disease (SCD), highlighting the unique nature of each case and elaborating on the high-risk patient groups often exhibiting this complication. Despite no guidelines existing for its treatment, Dr Eleftheriou emphasizes the need for red blood cell (RBC) exchange transfusions early on in FES treatment regimens to improve outcomes of patients. This interview took place at the 18th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) 2023, held in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
